Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Neuland Laboratories Ltd

NSE: NEULANDLAB · BSE: 524558 · Pharmaceuticals & Biotechnology · 34 announcements

Share price
₹21,655.00
Market cap
₹27,783 Cr
Revenue (annual)
₹2,023 Cr
Net profit (annual)
₹364.0 Cr
P/E (TTM)
55.8×Sector 47.3×
Promoter holding
32.62%-0.01% QoQ
FII holding
21.08%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:32 IST NSE
Management Change

Neuland Laboratories Management Change

Neuland Laboratories appointed Dr. Mauricio Futran as a Non-Executive Director effective May 12, 2026. He brings over 40 years of pharmaceutical manufacturing and strategic development experience.